Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer
- PMID: 31684733
- DOI: 10.21037/cco.2019.01.07
Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical